Table 2.
Selected indicators of Department of Defense influenza surveillance program growth, all sites, 2005–2008
| Fiscal year* | ILI samples processed | Influenza positive** | Influenza A | Influenza B | Original samples and isolates to CDC*** | Number of countries hosting ILI surveillance |
|---|---|---|---|---|---|---|
| 2005 | 11 940 | 2571 | 1057 | 858 | 550 | 24 |
| 2006 | 17 062 | 3382 | 2352 | 1015 | 444 | 29 |
| 2007 | 24 439 | 4976 | 3489 | 1278 | 148 | 56 |
| 2008 | 26 216 | 6089 | 3752 | 1750 | 522 | 72 |
| % Change, 2008 versus 2005 | 220 | 237 | 355 | 204 | 95 | 300 |
ILI, influenza‐like illness.
*DoD fiscal year: October 1 through September 30.
**By PCR test, culture or both.
***Influenza isolates or original samples requested by the WHO Collaborating Centre at the CDC, Atlanta, GA, USA, following initial characterization.
Sources of data: Internal reports by partners, March–April 2009, and Fiscal Year 2008 Annual Report, April 2009.